ArticleBMC women's health2025
Prevalence and determinants of exposure to family planning messages among reproductive age women in five Sub-Saharan African countries: a multilevel analysis of 2021-2023 demographic and health surveys.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cardiometabolic, Glycaemic, and Metabolic Safety of Hormonal Contraceptives in Women with Medical Conditions: A Systematic Review.International journal of women's health · 2026Review
- Bridging the Information Gap: A Spatial and Multilevel Analysis of Exposure to Family Planning Messages Among Women in Somaliland (SLHDS 2020).Women's health reports (New Rochelle, N.Y.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionWomen in many developing nations lack information about family spacing and contraceptives. Thus, nations worldwide frequently employ mass media to promote family planning and raise public awareness. Therefore, this study aims to ascertain the prevalence and factors associated with exposure messages on family planning among reproductive-age women in five sub-Saharan African countries.
methodDemographic and Health Survey data (2021-2023) from five sub-Saharan African countries (n = 48,133 women of reproductive age) were analyzed using STATA 17. Multilevel mixed-effects logistic regression identified significant factors (p < 0.05) associated with family planning message exposure, interpreted via adjusted odds.
resultThe prevalence of exposure to family planning messages was 56.29%. Maternal age groups 25-34 and 35-49 had adjusted odds ratios (AOR) of 1.49 and 1.59, one by one (95% CI: 1.36-1.64, 1.44-1.76). Maternal education levels primary, secondary, and higher had AORs of 1.52, 2.08, and 3.17, accordingly with (95% CI: 1.43-1.61, 1.95-2.23, 2.75-3.66) sequentially. Employed women had an AOR of 1.61 (95% CI: 1.54-1.69). Middle and rich socioeconomic statuses had AORs of 1.49 and 2.16, respectively with (95% CI: 1.41-1.58, 2.03-2.30). Distance to a health facility being a significant problem had an AOR of 1.09 with (95% CI: 1.04-1.14). Antenatal care (ANC) visits of 1-3 and ≥ 4 had AORs of 1.43 and 1.58, in turn with (95% CI: 1.25-1.46, 1.39-1.78). Community variables included urban residence (AOR: 1.16, 95% CI: 1.09-1.23), low illiteracy (AOR: 0.70, with 95% CI: 0.64-0.77), and low poverty (AOR: 1.19, 95% CI: 1.09-1.23). Country categories Burkina Faso, Ghana, Mozambique, and Tanzania had AORs of 1.00, 1.62, 0.55, and 0.73, respectively. These factors were significantly associated with exposure to family planning messages.
conclusionsThis study concluded that exposure message on family planning among reproductive-age women in five sub-Saharan African countries were high. Both individual and community-level variables as determinants of exposure message on family planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.